Single-cell multi-omic analysis of fibrolamellar carcinoma reveals rewired cell-to-cell communication patterns and unique vulnerabilities
Alaa R. FarghliiD, Marina ChaniD, Marc Samuel ShermaniD, Lindsay K. DickersoniD, Bo ShuiiD, Manabu NukayaiD, Andreas StephanouiD, Rosanna K. MaiD, Brian J. Pepe-MooneyiD, Colton J. SmithiD, Donald Long, Paul R. MunniD, Adrian J. McNairniD, Jennifer K. GrenieriD, Michael Karski, Sean M. Ronnekleiv‐KellyiD, Venu Gopal PillarisettyiD, Wolfram GoesslingiD, Taranjit S. GujraliD, Khashayar VakiliiD, Praveen Sethupathy
Abstract
Fibrolamellar carcinoma (FLC) is a rare malignancy disproportionately affecting adolescents and young adults with no standard of care. FLC is characterized by thick stroma, which has long suggested an important role of the tumor microenvironment. Over the past decade, several studies have revealed aberrant markers and pathways in FLC. However, a significant drawback of these efforts is that they were conducted on bulk tumor samples. Consequently, identities and roles of distinct cell types within the tumor milieu, and the patterns of intercellular communication, have yet to be explored. In this study we unveil cell-type specific gene signatures, transcription factor networks, and super-enhancers in FLC using a multi-omics strategy that leverages both single-nucleus ATAC-seq and single-nucleus RNA-seq. We also infer completely rewired cell-to-cell communication patterns in FLC including signaling mediated by SPP1-CD44, MIF-ACKR3, GDF15-TGFBR2, and FGF7-FGFR. Finally, we validate findings with loss-of-function studies in several models including patient tissue slices, identifying vulnerabilities that merit further investigation as candidate therapeutic targets in FLC.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Hotspots of aberrant enhancer activity in fibrolamellar carcinoma reveal molecular mechanisms of oncogenesis and intrinsic drug resistance
T. A. Dinh, R. Sritharan, … P. Sethupathy·bioRxiv·Jan 18, 2020
- DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma
R. K. Ma, P.-Y. Tsai, … P. Sethupathy·bioRxiv·Jun 2, 2023
- CDK7 is a Novel Therapeutic Vulnerability in Fibrolamellar Carcinoma
M. Nukaya, C. Cafferty, … S. M. Ronnekleiv-Kelly·bioRxiv·Apr 22, 2023
- Spatially discrete signalling niches regulate fibroblast heterogeneity in human lung cancer
C. J. Hanley, S. Waise, … G. J. Thomas·bioRxiv·Jun 8, 2020
- A fibroblast-centric network drives cold fibrosis in the tumor microenvironment of lung squamous cell carcinoma
Shoval Miyara, Shachaf Frenkel, … Uri Alon·bioRxiv·Aug 25, 2025
- Evaluation of PRKACA as a Therapeutic Target for Fibrolamellar Carcinoma
S. S. Schalm, E. O'Hearn, … K. P. Hoeflich·bioRxiv·Jan 31, 2022